AzTrials
AzTrials

Heart DiseasesNCT03584828

Tele-Cardiac Rehabilitation Program

A study testing Tele Cardiac Rehabilitation in people with Heart Diseases, run by Sheba Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Rehabilitation programs that take place in hospitals and rehabilitation centers and all over the world are a necessary stage for returning the patients after a cardiac event to a normal functioning. Read more about this study

Who is it for?
Ages 21 to 100 years
Conditions the study is for
Heart Diseases
What is being tested?
Tele Cardiac Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
264 participants
Where
1 siteIsrael
Study dates
Jul 2018to Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Eligible patients must meet all of the following inclusion criteria during the initial screening visit of the study (visit 1):
  • A guideline-based and Israeli Health Basket approved indications for cardiac rehabilitation yet participant declines to participate in center based cardiac rehabilitation due to non-medical reasons such as: distance, service availability in subjects living are, time constraints and other logistic or sociocultural barriers
  • Age ≥ 21
  • Compatible smartphone (android or iOS) with internet connection
  • Willing and able to comply with study protocol
  • Able and willing to follow the personalized exercise prescription, use wearable technology and smartphone app, and upload data via personal smartphone

Who cannot join

  • Eligible patients must meet none of the following exclusion criteria:
  • Any unresolved cardiac condition associated with significantly increased risk during outpatient activity (clinically significant ischemia, unresolved arrhythmia, high falling risk etc.)
  • End stage \ NYHA 4 or unstable heart failure (clinical) or unresolved significant arrhythmia (i.e. Rapid atrial fibrillation)
  • LVEF ≤35% without ICD \ CRTD
  • Significant neurological or cognitive impairment or markedly unstable gait \ high falling risk
  • Women of child-bearing potential
Show all 16Show fewer
  • ACS within 30 days prior to screening, or having undergone cardiac surgery within 30 days prior to screening
  • Inability to perform a stress test due to physical limitations
  • Severe angina pectoris as defined by CCS >2
  • Pulmonary disease of severity greater than mild (COPD, Asthma, ILD, CTD with lung involvement) or chronic pulmonary thromboembolic disease (CTED)
  • Severe orthopedic limitations
  • Active myocarditis, constrictive pericarditis, restrictive or hypertrophic cardiomyopathy
  • Severe Aortic or Mitral stenosis
  • Significant anemia (Hb <10 mg/dl)
  • Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or in the opinion of the investigator are not suitable to participate;
  • Any illness which reduces life expectancy to less than 1 year from screening

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Sheba Medical Center, Cardiac Rehabilitation Institute

    Tel Litwinsky, 52621

Other trials in Israel

About this study

Official title: Comprehensive Remote Multidisciplinary Cardiac Rehabilitation Program for Patients Unable to Attend an Institution Based Program

Rehabilitation programs that take place in hospitals and rehabilitation centers and all over the world are a necessary stage for returning the patients after a cardiac event to a normal functioning. However, about 70% of patients do not apply for the hospital rehabilitation programs after the heart event that they experience. The objective of this study is to evaluate and develop a multi-stage home rehabilitation program for remote rehabilitation, based on advanced technological infrastructure and complementary clinical protocols. The study population will include about 264 clinically stable patients who are eligible for cardiac rehabilitation, but for various reasons cannot get to the rehabilitation centers.

Read the detailed description

Cardiac rehabilitation (CR) is an integral part of cardiovascular disease management incorporating aspects of scientifically constructed appropriate physical exercise, dietary intervention, secondary prevention by pharmacotherapy, and psychological intervention. Despite proven benefits including reduction in mortality, hospitalizations and marked improvement in well-being and function state, the current model is restrictive and requires patients' arrival to the hospital twice a week at predetermined hours. Major limitations associated with lack of participation in an in-hospital based cardiac rehabilitation program in 20-40% of eligible patients include limited transportation, time and social/family restraints, and inconvenience. Furthermore, the limited space, even in the largest rehabilitation in Israel located at Sheba Medical Center, prohibits wider availability. Leading key opinions leaders have designated cardiac-telerehabilitation as the most viable solution for the above-mentioned limitations, and several clinical studies have demonstrated safety and efficacy of this approach, including a Cochrane review and a recent meta-analysis. Nevertheless, tele-cardiac rehabilitation is not guideline recommended yet, and prospective randomized trials are necessary to better evaluate its role.

Study will enroll patients who are eligible to participate in an in-hospital cardiac rehabilitation program but are unable to participate due to one of the above-mentioned limitations, in a structured exercise and secondary prevention program in their communities. Consenting patients will undergo a baseline cardiopulmonary exercise test (CPET) followed by randomization to usual care vs. multidisciplinary intervention as described.

In addition to monitored physical activity, patients will receive nutritional and psychological counseling. This is part of a multi-professional rehabilitation program accepted by the rehabilitation center.

The study will enroll and randomize 264subjects to usual care vs. comprehensive tele-cardiac rehabilitation (TCR) with disease management services and demonstrate a greater improvement in functional capacity (O2 consumption) and improved clinical outcomes (secondary endpoints) in the TCR group.

Concomitant medications and guidelines: As indicated by national guidelines. No limitations

Study Duration: 12-month intervention period. Primary endpoint (percent change in O2 consumption) will be assessed following 3 months of intervention. Clinical event adjudication (hospitalizations, emergency department visits) will be performed throughout a 12-month period from enrollment.

Study Design: The study is an open-labeled double arm randomized prospective multi-center study designed to assess the effects of tele-CR compared to usual care in subjects that are unable to attend institution based CR despite compelling indications to CR. The intervention will be evaluated against usual care by family physician and cardiologist. The multidisciplinary program will include elements of education, nutritional and psychological interventions, monitored personalized exercise and medication titration according to the relevant national guidelines. The present sample will facilitate an evaluation of the hypothesis that tele-rehabilitation will be associated with a significant improvement in functional capacity, as assessed by the gold standard of CPET. We also hypothesize that the comprehensive intervention will also reduce clinical events, including all-cause hospitalization and death.

All subjects will undergo a detailed evaluation by rehabilitation specialist, nurse case manager, trainers and exercise physiologists. Both research arms will receive a dedicated application with a built-in pedometer and the ability to answer questionnaires.

Conditions
Heart Diseases
Being tested
Tele Cardiac Rehabilitation
Keywords
Cardiac Rehabilitation, exercise
Medical subject headings
Heart Diseases, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tele Cardiac RehabilitationBehavioural

    A multidisciplinary intervention that aims to optimize structured exercise performed in the community as prescribed by rehabilitation cardiologist, cardiac care nurse, and exercise physiologist.

    Additionally, in the intervention arm, we will provide psychological support, dietary intervention and disease management services that complement the structured physical activity - all by innovative smartphone applications and smart wearable devices, thus complementing the comprehensive secondary prevention program.

Study groups in NCT03584828
Study groupRoleWhat they receive
Tele-Rehabilitation - interventionExperimentalFollowing the standard rehabilitation intake process the subjects in the Tele-rehaab arm will receive physiologic consultation based on clinical stress tests and clinical data passed from the physician. The Tele-rehab arm will receive an exercise prescription and execution will be assessed and periodically adjusted in accordance to data received from the wearable device. Intensity and type of exercise will be moderate and will comply with exercise recommendations provided by ESC guidelines. A dedicated application will be installed on the mobile phone for patients in the research group and they will receive a smart sports watch.
Receives: Behavioral: Tele Cardiac Rehabilitation
Usual careNo interventionThe usual care arm will receive general recommendations for a healthy and active lifestyle and community cardiologist and primary care physician according to local guidelines.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in METS

    Exercise capacity change by stress test

    Measured: 6 month

Secondary outcomes (14)
  1. First CV hospitalization or death

    Time to first cardiovascular hospitalization or death

    Measured: 1-12 month

  2. Health status

    General clinical status (worsened\ unchanged\ improved)

    Measured: 1-12 month

  3. QOL

    Assessed by validated questioner

    Measured: 1-12 month

  4. Time alive and out of hospital

    Measured: 1-12 month

  5. Depression

    Assessed by PHQ-9

    Measured: 1-12 month

  6. Time to return to work

    (if applicable)

    Measured: 1-12 month

  7. Medication compliance

    Use of guideline recommended medication and dose attained (% of target)

    Measured: 1-12 month

  8. Fasting Glucose

    levels of fasting blood glucose

    Measured: 1-12 month

  9. Activity

    average weekly steps

    Measured: 1-6 month

  10. TCR group adherence

    Percent of total exercise time at the designated target heart rate zone

    Measured: 1-6 month

  11. TCR group sessions > 10 min adherence

    Number of exercise sessions > 10 minutes per month (within target heart rate designated zone)

    Measured: 1-6 month

  12. Lipid profile

    Lipid profile dynamics

    Measured: 1-6 months

  13. Diabetes management

    HB A1C %

    Measured: 1-6 months

  14. BMI

    Change in BMI from baseline to 3 and 6 months

    Measured: 1-6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2018
  2. Study startJul 2018 (estimated)
  3. Primary completionNov 2019 (estimated)
  4. Study completionJul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
264 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03584828
Sponsor's protocol ID
4916-18 -SMC
Status last verified
Jul 2018
First submitted
24 Jun 2018
Last updated
12 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Tele Cardiac Rehabilitation in people with Heart Diseases, run by Sheba Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in METS (time frame: 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2018; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in